United States · FDA National Drug Code directory

Buspirone hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-975_45c63c90-30a3-54ff-e063-6394a90af15f
Product NDC
71610-975
Form
TABLET
Composition / generic term
Buspirone hydrochloride
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
ANDA
Marketing start / end (source format)
20250918
Source listing expiry
20261231

Source-listed ingredients

  • BUSPIRONE HYDROCHLORIDE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 TABLET in 1 BOTTLE (71610-975-60) · 71610-975-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →